Filing Details
- Accession Number:
- 0001209191-11-061243
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-12-14 15:35:28
- Reporting Period:
- 2011-12-12
- Filing Date:
- 2011-12-14
- Accepted Time:
- 2011-12-14 15:35:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337801 | W Randal Scott | 301 Penobscot Drive Redwood City CA 94403 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-12-12 | 9,900 | $27.56 | 1,371,246 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-12-12 | 100 | $28.46 | 1,371,146 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-12-13 | 7,890 | $26.88 | 1,363,256 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-12-13 | 2,110 | $27.50 | 1,361,146 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,298 | Indirect | By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA |
| Common Stock | 3,466 | Indirect | Held in trust for the benefit of Dr.Scott's children, of which Dr. Scott's sister is trustee. |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 6, 2010.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $27.31 to $28.07.
- Represents actual sale price.
- Represents weighted average sale price. Actual sale prices ranged from $26.34 to $27.31.
- Represents weighted average sale price. Actual sale prices ranged from $27.36 to $27.71.
- Includes 10,000 restricted stock units awarded January 27, 2011 which vest as to 1/3 of the shares on February 15, 2012, 1/3 of the shares on February 15, 2013 and 1/3 of the shares on February 15, 2014.
Billionaire Hedge Funds
